|
Weekly Update | September 20, 2010 |
|
|
FDA Commissioner Margaret A. Hamburg to Keynote Partnership
for Safe Medicines Inaugural Counterfeit Drug Conference
Speaker
Lineup Includes Counterfeit Drug Victims, Journalists and Law Enforcement Officials Washington,
D.C. (September 9, 2010) - The Partnership for Safe Medicines (PSM) today
announced that Dr. Margaret A. Hamburg, Commissioner of the Food and Drug
Administration, will be the keynote speaker at its inaugural Interchange
conference to be held October 8th at the National Press Club in Washington,
D.C.
|
|
"Dr. Hamburg
brings a tremendous amount of experience and insight to this issue and we are
thrilled to have her join us for this important discussion," said Scott
LaGanga, executive director of PSM. "It's clear we have a near-term opportunity
to advance meaningful solutions that address the counterfeit drug trade head
on."
Dr. Hamburg,
who became the 21st FDA Commissioner on May 18, 2009, is only the second woman
in history to serve in the position.
PSM also
announced the addition of Dr. Michael Green, researcher at the Center for
Disease Control, Division of Parasitic Diseases, and Bejon Misra, Founder of
PSM India. Dr. Green's areas of interest include anti malarial drug analysis
for pharmacokinetic and drug quality studies and developing simple inexpensive
field tests to assess drug quality of pharmaceuticals.
Other
panelists announced today include John Gray, President and CEO of the
Healthcare Distribution Management Association, Rick Roberts, a counterfeit
drug victim, Nancy Kennedy, senior operations manager for the FDA Office of
Criminal Investigations, pharmaceutical abuse investigator Charlie Cichon and
journalist Walt Bogdanich from the New York Times will be panelists at the Interchange.
Panels will be moderated by PSM Board Members Marv Shepherd, Bryan Liang and
Thomas Kubic.
For more
information, a current agenda and registration forms for the Interchange,
please visit: http://interchange.safemedicines.org.
|
Top News
Counterfeit Drug Infiltration of the
Legitimate Supply Chain
In a recent
investigation, Dan Rather examined the fake prescription medication market and
attempts of counterfeiters to infiltrate the US market. Dan Rather spoke to
Andre Watson, US special agent in charge of immigration and customs enforcement
regarding a counterfeit medicine smuggler named Mr. Xu who had access to
extensive manufacturing and distribution capabilities in China to produce fake,
chemically inaccurate version of influenza vaccines, prostate cancer treatment,
blood thinners, Alzheimer's medication and other vital drugs. After six years
of selling fake medications wholesale inside legitimate pharmacies in Europe,
he began selling them in the U.S. Finally, U.S. Agents infiltrated Mr. Xu's
large-scale phony drug production line, which could produce 200,000 boxes of
counterfeit drugs in a week. (Partnership
for Safe Medicines, September 15, 2010; Link
here) Click here
for the full transcript. The complete episode can be purchased here.
Growing Problem of Counterfeit Drugs is
Hurting Patients, Companies According to
the Pharmaceutical Security Institute (PSI), nearly 1,700 incidents of
counterfeit drugs were reported worldwide last year which is triple the number
from 2004. Moreover, estimates for the size of the counterfeit drug market
range from $75 billion to $200 billion a year although the market is likely
much bigger because many cases are hard to detect. A weak economy along with
rising drug prices can lead to consumers seeking out cheaper products online or
from unauthorized providers, says Bryan Liang, a board member at the
Partnership for Safe Medicines. Counterfeiters are now able to create such
convincing fake drugs, even experts find it hard to distinguish the copies from
the real deal. Tom Kubic, CEO of PSI points out that "You can make more
money in counterfeit drugs than heroin. There's a major financial incentive for
criminals because of the low risk of detection and prosecution." ("Growing
Problem of Fake Drugs Hurting Patients, Companies," USA Today, September 12, 2010; Story
here)
|
World News
Russia: Government Adopts New Rules for Destruction
of Counterfeit Drugs Russia
recently adopted new guidelines for the destruction of counterfeit drugs as
well as for medications that are substandard. The new law, which was passed on
September 3, will require that the destruction of all fake drugs be handled by
organizations that are licensed for the collection, transportation and disposal
of grade I-IV waste, according to SecuringPharma.com. The legislation also
recommends that such organizations should have access to specialized facilities
where the counterfeit drugs can be disposed of with the proper equipment. (Partnership for Safe Medicines,
September 16, 2010; Link
here)
Israel: Lifestyle Drugs are the Most
Prevalent Counterfeits Knowingly or
unknowingly, It is estimated that 1 out of every 100 Israelis buys counterfeit
drugs at one time. The most widely sold counterfeit drug in Israel is a
counterfeit version a lifestyle drug produced by drug manufacturer Pfizer. According
to the company, between 2007 and 2009, Israeli authorities reported that they
had 438,410 pills identified by Pfizer as counterfeit versions of their drug
and this was only based on reported cases. Recent media reports point to
seizures of a wide variety of counterfeit drugs including those to treat
malaria, tuberculosis, and anxiety, as well diet drugs and antibiotics. ("Fake
[Lifestyle Drugs] Most Prevalent Counterfeit Drug in Israel," Globes, September 15, 2010; Story
here) |
Events
PSM's Inaugural 2010 Interchange When: Friday, Oct 8, 2010 Where: Washington, D.C. The Partnership for Safe Medicines invites you to save the date for an intimate conference bringing together patient groups, providers, pharmaceutical company quality experts, enforcement personnel, policymakers, regulatory agency experts and other interested parties to discuss key issues around counterfeit drugs and other unsafe medicines.
 |
|
About the Partnership for Safe Medicines
The Partnership for Safe Medicines is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines. For more information, please visit SafeMedicines.org.
| |
|